AbbVie Humira Lawsuit Withstands Alvotech Attack
Attempt Fails To Dismiss Adalimumab Litigation Ahead Of FDA Decision On AVT02 Biosimilar
Alvotech has failed in an attempt to dismiss US litigation initiated by AbbVie over Alvotech’s AVT02 proposed rival to higher-strength Humira. The company is expecting an FDA decision on the adalimumab biosimilar this month.
